NCT05252416 2025-11-28(VELA) Study of BLU-222 in Advanced Solid TumorsBlueprint Medicines CorporationPhase 1 Terminated50 enrolled
NCT03365791 2022-05-27PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesNovartisPhase 2 Completed76 enrolled 14 charts
NCT00633789 2015-10-09Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor TypesBristol-Myers SquibbPhase 2 Completed597 enrolled
NCT00073944 2013-05-30BCX-1777 in Treating Patients With Refractory CancerNational Cancer Institute (NCI)Phase 1 Completed